Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study.
Saved in:
| Title: | Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study. |
|---|---|
| Authors: | Terpos, Evangelos1 (AUTHOR) eterpos@med.uoa.gr, Ntanasis-Stathopoulos, Ioannis1 (AUTHOR) mdeleutherakis@gmail.com, Katodritou, Eirini2 (AUTHOR) eirinikatodritou@gmail.com, Kyrtsonis, Marie-Christine3 (AUTHOR) kyrtsoni@med.uoa.gr, Douka, Vassiliki4 (AUTHOR) vassiliki.douka@gmail.com, Spanoudakis, Emmanouil5 (AUTHOR) emmanouilspanoudakis@yahoo.com, Papatheodorou, Athanasios6 (AUTHOR) atpapath@med.uoa.gr, Eleutherakis-Papaiakovou, Evangelos1 (AUTHOR) nick.kanellias@gmail.com, Kanellias, Nikolaos1 (AUTHOR) mariagabria@gmail.com, Gavriatopoulou, Maria1 (AUTHOR) ekastritis@gmail.com, Makras, Polyzois6 (AUTHOR) makras@internet.gr, Kastritis, Efstathios1 (AUTHOR) mdimop@med.uoa.gr, Dimopoulos, Meletios A1 (AUTHOR), Atanackovic, Djordje (AUTHOR) |
| Source: | Cancers. Mar2021, Vol. 13 Issue 6, p1257. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
